EVENTIDE ASSET MANAGEMENT, LLC
Q4 2020 13F-HR Holdings
Net value change ($000)
+1,412,556
(27.7%)
New positions
23
Sold out positions
14
Turnover %
13.2%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| PRAX | 183,766 | NEW |
| CRWD | 75,721 | 55.4% |
| TTD | 61,242 | 39.2% |
| FIVN | 53,616 | 35.7% |
| EXAS | 53,140 | 30.0% |
| VITL | 51,967 | NEW |
| YETI | 47,244 | NEW |
| GTM | 46,700 | 104.1% |
| IDXX | 40,954 | 51.8% |
| RNG | 38,060 | 87.0% |
Top Reduces (Value $000, Stocks/ETFs)
| MyoKardia, Inc. | -84,661 | -100.0% |
| W | -76,899 | -45.9% |
| IPHI | -51,004 | -100.0% |
| RCKT | -35,433 | -100.0% |
| SPLUNK INC | -34,096 | -100.0% |
| Global Blood Therapeutics, Inc. | -29,500 | -100.0% |
| VMC | -25,346 | -100.0% |
| Mirati Therapeutics, Inc. | -21,544 | -43.1% |
| Atlantica Sustainable Infrastructure plc | -21,057 | -100.0% |
| Seagen Inc. | -20,058 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
72,572
(1.1% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|